Eutilex Competitors and Similar CompaniesClear all

Eutilex's competitors and similar companies include Zymeworks, Coherus BioSciences and JW Therapeutics.
Eutilex
Eutilex
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Coherus BioSciences
Coherus BioSciences
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
JW Therapeutics
JW Therapeutics
JW Therapeutics is a biotech company focusing on clinical cell therapy technology.
Founding Date
Founding Date
2015
Founding Date
2003
Founding Date
2010
Founding Date
2016
Type
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
KR HQ
Locations
Vancouver, CA HQ
Seattle, US
Locations
Redwood City, US HQ
Camarillo, US
Locations
CN HQ
Suzhou Shi, CN
Employees
Employees
90
Employees
45519% increase
Employees
30615% decrease
Employees
1052% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
731.8 m
Valuation ($)
189.3 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
3.7 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.9
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
81.25%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
₩131.7m (FY, 2023)
Revenue (est.)
$76m (FY, 2023)
Revenue (est.)
$257.2m (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$159m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
₩217.5m (FY, 2023)
Gross profit
N/A
Gross profit
$98.3m (FY, 2023)
Gross profit
N/A
Net income
Net income
(₩28.3b) (FY, 2023)
Net income
($118.7m) (FY, 2023)
Net income
($237.9m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 18.9m
Total funding raised
$ 125.9m
Total funding raised
$ 174.5m
Total funding raised
$ 90m
For sources of this data, please see the company profile

View Company Profiles

Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

View company
Coherus BioSciences
HQ
Redwood City, US
Employees
306↓ 15% decrease

Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.

View company
JW Therapeutics
HQ
CN
Employees
105↓ 2% decrease

JW Therapeutics is a biotech company focusing on clinical cell therapy technology.

View company